학술논문
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Document Type
Article
Author
Source
In The Lancet Respiratory Medicine May 2019 7(5):437-446
Subject
Language
ISSN
2213-2600